Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Gary A. Lyons files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Eric M. Dube - $15.95M of TVTX open-market activity in the last 12 months
- Elizabeth E. Reed - $4.93M of TVTX open-market activity in the last 12 months
- Sandra Calvin - $3.56M of TVTX open-market activity in the last 12 months
- Roy D. Baynes - $2.55M of TVTX open-market activity in the last 12 months
- Jula Inrig - $1.74M of TVTX open-market activity in the last 12 months
- Christopher R. Cline - $1.46M of TVTX open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Gary A. Lyons?
Gary A. Lyons is a corporate insider, tracked as Director of Travere Therapeutics, Inc. (TVTX). InsiderAlpha holds 9 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Gary A. Lyons submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Gary A. Lyons been buying or selling stock?
Recorded transactions: 0 open-market purchases and 9 open-market sales ($3.84M) across all tracked filings.
Where can I see all of Gary A. Lyons's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Gary A. Lyons and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
